ArticleNPJ precision oncology2025
ECT2
Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tumor heterogeneity: development, mechanisms, and therapeutic implications.Signal transduction and targeted therapy · 2026Review
- Large Pleomorphic Adenoma of The Upper Lip in a Middle-Aged Woman With Facial Deformity, Tooth Displacement, and Bone Loss: Uncommon Clinical Presentation of a Benign Tumor.Case reports in dentistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Salivary carcinoma ex pleomorphic adenoma (CXPA) is a carcinoma that develops from benign pleomorphic adenoma, and it is characterized by aggressiveness and poor prognosis. Recent advancements in cancer stem cell (CSC) research have identified CSCs as critical contributors to tumor carcinogenesis due to their unlimited self-renewal ability. Single-cell RNA sequencing has enabled a comprehensive analysis of CSC heterogeneity. However, CSCs in CXPA remain largely unexplored. In this study, we constructed a comprehensive atlas of CXPA at single-cell resolution and demonstrated that CXPA exhibited intratumoral heterogeneity. We identified four tumor epithelial cell subgroups characterized by epithelial development, cell cycle, extracellular matrix remodeling, and salivary secretion signatures. ECT2
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.